![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Swallowfield Plc | LSE:SWL | London | Ordinary Share | GB0008667304 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 195.00 | 190.00 | 200.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMBAR
RNS Number : 2797J
Brand Architekts Group PLC
26 April 2022
Brand Architekts Group plc
("Brand Architekts" or the "Group")
Notice of Investor Presentation
Brand Architekts Group plc, a market leader in the development and supply of beauty and personal care brands, announces that on 5 May 2022 at 4.30 p.m. (BST), it intends to host a virtual presentation alongside certain InnovaDerma Board members.
This presentation is intended chiefly to be for the benefit of InnovaDerma and BrandArchitekts Shareholders, during which the benefits of the Merger envisaged by both boards will be explained, including the reasons why the Merger should be attractive to Brand Architekts and InnovaDerma Shareholders alike.
The presentation is open to all existing and potential shareholders of Innovaderma and Brand Architekts. To access the presentation, InnovaDerma and BrandArchitekts Shareholders can sign up to Investor Meet Company for free and add to meet Brand Architekts Group Plc via: https://www.investormeetcompany.com/brand-architekts-group-plc/register-investor . Investors who already follow Brand Architekts on the Investor Meet Company platform will automatically be invited.
If shareholders of InnovaDerma and BrandArchitekts wish to raise questions in advance of that presentation, they can do so, via their Investor Meet Company "dashboard" accessible through the link above. All questions must be submitted prior to the presentation and must be received by Brand Architekts by no later than 9 a.m. (BST) on 4 May 2022. To the extent that the Brand Architekts Board is able, and in line with restrictions and obligations applying under the Takeover Code and under applicable law, it will endeavour to answer as many of those questions as possible, during the virtual presentation.
A recorded version of that presentation and associated materials including the Q&A will also subsequently be available via the respective websites of InnovaDerma and Brand Architekts, until the end of the Offer Period, at https://www.innovaderma.com/recommended-offer-for-innovaderma/ and at https://www.brandarchitektsplc.com/merger-innovaderma-plc .
For further information please contact: Brand Architekts Group PLC via Alma Quentin Higham / Tom Carter Singer Capital Markets (Nominated adviser and Shaun Dobson / Jen Boorer broker) 0207496 3000 Alma PR Josh Royston / Sam Modlin 0203 405 0205
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
MSCUVRKRURUSUAR
(END) Dow Jones Newswires
April 26, 2022 02:01 ET (06:01 GMT)
1 Year Swallowfield Chart |
1 Month Swallowfield Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions